BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23688014)

  • 1. What fans the fire: insights into mechanisms of leptin in metabolic syndrome-associated heart diseases.
    Dong M; Ren J
    Curr Pharm Des; 2014; 20(4):652-8. PubMed ID: 23688014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
    Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
    Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin and hyperleptinemia - from friend to foe for cardiovascular function.
    Ren J
    J Endocrinol; 2004 Apr; 181(1):1-10. PubMed ID: 15072562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of cardiovascular complications in chronic kidney disease: a possible role of leptin.
    Korolczuk A; Dudka J
    Curr Pharm Des; 2014; 20(4):666-74. PubMed ID: 23688007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failure.
    Karmazyn M; Rajapurohitam V
    Curr Pharm Des; 2014; 20(4):646-51. PubMed ID: 23688017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin as a predictive marker for metabolic syndrome.
    Ghadge AA; Khaire AA
    Cytokine; 2019 Sep; 121():154735. PubMed ID: 31154250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin in thrombosis and atherosclerosis.
    Wang H; Luo W; Eitzman DT
    Curr Pharm Des; 2014; 20(4):641-5. PubMed ID: 23688009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin and vascular smooth muscle cells.
    Trovati M; Doronzo G; Barale C; Vaccheris C; Russo I; Cavalot F
    Curr Pharm Des; 2014; 20(4):625-34. PubMed ID: 23688016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease.
    Rask-Madsen C; Kahn CR
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2052-9. PubMed ID: 22895666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin and the cardiovascular system.
    Rahmouni K; Haynes WG
    Recent Prog Horm Res; 2004; 59():225-44. PubMed ID: 14749504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and cardiovascular diseases.
    Hou N; Luo JD
    Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):905-13. PubMed ID: 21957899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targets.
    Schäfer K; Konstantinides S
    Curr Pharm Des; 2014; 20(4):635-40. PubMed ID: 23688015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness or fatness--the debate continues for the role of leptin in obesity-associated heart dysfunction.
    Dong F; Ren J
    Curr Diabetes Rev; 2007 Aug; 3(3):159-64. PubMed ID: 18220667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance, cardiovascular stiffening and cardiovascular disease.
    Hill MA; Yang Y; Zhang L; Sun Z; Jia G; Parrish AR; Sowers JR
    Metabolism; 2021 Jun; 119():154766. PubMed ID: 33766485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.
    Knudson JD; Payne GA; Borbouse L; Tune JD
    Curr Hypertens Rep; 2008 Dec; 10(6):434-9. PubMed ID: 18959828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications.
    Mark AL; Correia ML; Rahmouni K; Haynes WG
    J Hypertens; 2002 Jul; 20(7):1245-50. PubMed ID: 12131511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney.
    Nasrallah MP; Ziyadeh FN
    Semin Nephrol; 2013 Jan; 33(1):54-65. PubMed ID: 23374894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapy.
    Bełtowski J; Jazmroz-Wiśniewska A
    Curr Pharm Des; 2014; 20(4):616-24. PubMed ID: 23688012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.